Geron | GERN - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Amgen USD 1.51B 2.41B 2025-12
Bio Techne USD 50.78M 34.21M 2025-12
Cassava Sciences USD -10.81M 33.41M 2025-09
Cytokinetics USD -206.03M 23M 2026-03
Esperion Therapeutics USD 63.67M 95M 2025-12
Exelixis USD 267.69M 15M 2026-03
Genmab DKK 55M 427M 2025-12
Geron USD -3.64M 27.5M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Incyte USD 343.6M 46.34M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Novartis USD 3.84B 802M 2026-03
Novavax USD 17.9M 220.94M 2025-12